Sharif Shajib, Md. Wang, Huaqing Kim, Janice J. Sunjic, Ivana Ghia, Jean-Eric Denou, Emmanuel Collins, Matthew A. Denburg, Judah I. Khan, Waliul Effects of replenishment of IL-13 in DSS-induced colitis. <p>IL-13−/− mice were treated with rmIL-13 (2 µg/day) injections or vehicle. rmIL-13 treatment started 3 days prior to 5 days of 5% DSS treatment. All groups received 5% DSS in the drinking water to induce colitis. (A) Number of 5-HT expressing EC cells per 10 glands and (B) colonic 5-HT content. (i) and (ii) Representative micrograph and arrows indicate 5-HT expressing EC cells. *Represents statistical significance where p<0.05.</p> histology;immunology;Immune cells;monocytes;Immune system;cytokines;immunity;inflammation;Immune response;Model organisms;Animal models;mouse;Gastroenterology and hepatology;Inflammatory bowel disease;ulcerative colitis;replenishment;il-13;dss-induced 2013-08-28
    https://plos.figshare.com/articles/figure/_Effects_of_replenishment_of_IL_13_in_DSS_induced_colitis_/783120
10.1371/journal.pone.0072774.g007